Two top healthcare ETFs, XLV and FHLC, offer nearly identical low fees but different strategies: XLV targets 60 giant healthcare names like J&J and Eli Lilly with a 1.6% dividend, while FHLC spreads across 360+ stocks—including smaller caps—for broader exposure and a slightly higher 10-year return. Both lag the S&P 500 but share similar risk, making XLV ideal for mega-cap focus and FHLC better for diversified growth.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
